...
首页> 外文期刊>Metabolic brain disease >Neuroprotective effect of N-acetylcysteine in the development of diabetic encephalopathy in streptozotocin-induced diabetes.
【24h】

Neuroprotective effect of N-acetylcysteine in the development of diabetic encephalopathy in streptozotocin-induced diabetes.

机译:N-乙酰半胱氨酸对链脲佐菌素诱发的糖尿病糖尿病性脑病发展的神经保护作用。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Diabetic encephalopathy is characterized by impaired cognitive functions that involve neuronal damage triggered by glucose driven oxidative stress. The objective of the present study was to determine whether N-acetylcysteine (NAC) supplementation ameliorates learning and memory deficits caused by hyperglycemia-induced oxidative stress in experimental diabetes. Male Wistar rats (200-250 g) were rendered diabetic by a single intraperitoneal injection of streptozotocin (50 mg/kg). Cognitive deficits were observed in diabetic animals assessed using elevated plus maze test after 8 weeks of induction of diabetes. Acetylcholinesterase activity, a marker of cholinergic function, was decreased by 15.6% in the cerebral cortex, 20.9% in cerebellum and 14.9% in brain stem of diabetic rats compared to control rats. There was an increase in lipid peroxidation in cerebral cortex (21.97%), cerebellum (20.4%) and brain stem (25.5%) of diabetic rats. This was accompanied by decrease in glutathione and total thiol content along with decrease in the activities of superoxide dismutase, catalase and glutathione reductase. However, glutathione peroxidase activity increased by 11.2%, 13.6% and 23.1% in cerebral cortex, cerebellum and brain stem respectively, while the activity of glutathione-s-transferase decreased only in cerebral cortex (21.7%). Supplementation with NAC (1.4 g/kg/day in drinking water) significantly attenuated cognitive deficits and oxidative stress in diabetic rats. Our results emphasize the involvement of increased oxidative stress in cognitive impairment in diabetic animals and point towards the potential beneficial role of NAC as an adjuvant therapy to conventional anti-hyperglycemic regimens for the prevention and treatment of diabetic encephalopathy.
机译:糖尿病性脑病的特征是认知功能受损,涉及葡萄糖驱动的氧化应激触发的神经元损伤。本研究的目的是确定N-乙酰半胱氨酸(NAC)补充剂是否可以改善实验性糖尿病中由高血糖引起的氧化应激引起的学习和记忆障碍。通过腹膜内注射链脲佐菌素(50 mg / kg)使雄性Wistar大鼠(200-250 g)患有糖尿病。在诱导糖尿病8周后,使用升高的迷宫测试评估的糖尿病动物中观察到认知缺陷。与对照组相比,糖尿病大鼠的大脑皮层乙酰胆碱酯酶活性降低了15.6%,小脑降低了20.9%,小脑降低了14.9%。糖尿病大鼠的大脑皮层(21.97%),小脑(20.4%)和脑干(25.5%)的脂质过氧化增加。这伴随着谷胱甘肽和总硫醇含量的降低,以及超氧化物歧化酶,过氧化氢酶和谷胱甘肽还原酶活性的降低。然而,谷胱甘肽过氧化物酶活性在大脑皮层,小脑和脑干中分别增加了11.2%,13.6%和23.1%,而谷胱甘肽-s-转移酶的活性仅在大脑皮层中降低(21.7%)。补充NAC(在饮用水中为1.4 g / kg /天)可显着减轻糖尿病大鼠的认知缺陷和氧化应激。我们的研究结果强调了糖尿病动物认知障碍中氧化应激的增加,并指出了NAC作为预防糖尿病性脑病的常规抗高血糖方案的辅助疗法的潜在有益作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号